GlaxoSmithKline PLC
Company Cash Flow
| Dec 2007 | Dec 2006 | Dec 2005 | Dec 2004 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 10.54B | 10.77B | 11.82B | 11.68B |
| Operating Gains/Losses | 623.00M | -3.35B | -76.00M | 109.00M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -157.00M | -1.04B | -683.00M | -857.00M |
| (Increase) Decrease in Inventories | -907.00M | -584.00M | 81.00M | -63.00M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -371.00M | 693.00M | 845.00M | 313.00M |
| (Decrease) Increase In Other Current Liabilities | -244.00M | -529.00M | -373.00M | -372.00M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 716.00M | 697.00M | -2.92B | -3.50B |
| Net Cash From Continuing Operations | 12.23B | 8.53B | 10.25B | 9.02B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 12.23B | 8.53B | 10.25B | 9.02B |
| Sale of Property, Plant & Equipment | 87.00M | 427.00M | 93.00M | 182.00M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 111.00M |
| Purchases of Property, Plant & Equipment | -4.25B | -3.11B | -1.55B | -1.66B |
| Acquisitions | -2.04B | -525.00M | -1.76B | -569.00M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -197.00M |
| Other Cash from Investing Activities | 144.00M | 308.00M | 369.00M | 15.00M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -5.97B | -2.98B | -2.86B | -2.12B |
| Issuance of Debt | 10.15B | 0.00 | 1.69B | 2.62B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.06B | 915.00M | 550.00M | 125.00M |
| Repayment of Long-Term Debt | -488.00M | -1.51B | -1.66B | -851.00M |
| Repurchase of Capital Stock | -7.45B | -2.64B | -1.72B | -2.86B |
| Payment of Cash Dividends | -5.54B | -5.09B | -4.26B | -4.74B |
| Other Financing Charges, Net | -1.19B | -1.06B | 383.00M | -1.84B |
| Net Cash From Financing Activities | -3.46B | -9.39B | -5.01B | -7.54B |
| Effect of Exchange Rate Changes | 95.00M | -497.00M | 401.00M | 0.00 |
| Net Change in Cash & Cash Equivalents | 2.90B | -4.33B | 2.78B | -644.00M |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas